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a b s t r a c t
Early events in the pathogenesis of foot-and-mouth disease virus (FMDV) infection in cattle were
investigated through aerosol and intraepithelial lingual (IEL) inoculations of a cDNA-derived FMDV-A24
wild type virus (FMDV-WT) or a mutant derived from the same clone (FMDV-Mut). After aerosolization
of FMDV-WT, primary infection sites had signiﬁcantly greater quantities of FMDV, viral RNA, and type I/III
interferon (IFN) activity compared to corresponding tissues from cattle infected with FMDV-Mut.
Additionally, FMDV-WT-infected cattle had marked induction of systemic IFN activity in serum. In
contrast, FMDV-Mut aerosol-infected cattle did not manifest systemic IFN response nor had viremia.
Interestingly, IEL inoculation of FMDV-Mut in cattle restored the virulent phenotype and systemic IFN
response. These data indicate that the attenuated phenotype in cattle is associated with decreased
replicative efﬁciency, reﬂected by decreased innate response. However, attenuation is abrogated
by bypassing the common primary infection sites, inducing accelerated viral replication at the
inoculation site.
Published by Elsevier Inc.
Introduction
Foot-and-mouth disease virus (FMDV; family Picornaviridae;
genus Aphthovirus) is the cause of a highly contagious, acute
disease of cloven-hoofed animals characterized by fever, lameness,
and vesicular lesions of the feet, tongue, snout, and teats
(Alexandersen et al., 2003; Arzt et al., 2011b; Grubman and Baxt,
2004). In recent years there have been several breakthroughs in
elucidating functions of FMDV proteins (Borca et al., 2012; Gladue
et al., 2012; Lawrence et al., 2012; Pacheco et al., 2013); yet, the
FMDV leader protein, Lpro, remains the most thoroughly investi-
gated determinant of virulence (reviewed in (Arzt et al., 2011a)).
Virus constructs lacking the Lpro sequence (leaderless FMDV) have
been shown to be avirulent in cattle and pigs (Brown et al., 1996;
Chinsangaram et al., 1998; Uddowla et al., 2012). Cattle exposed to
leaderless FMDV by aerosol do not develop viremia or clinical
signs of FMD (Brown et al., 1996; Uddowla et al., 2012) and have
minimal quantities of viral RNA (vRNA) detected in lungs by in situ
hybridization (ISH) and no vRNA detected in any other tissues
(Brown et al., 1996). More recently, FMDV mutants with in-frame
insertions in Lpro were shown to be markedly attenuated in cattle
(Piccone et al., 2010b). These viruses had a more extensive
dissemination within the respiratory tract (compared to leaderless
FMDV) after aerosol inoculation in cattle; but, similar to the
leaderless virus, neither viremia nor clinical disease were detected
(Brown et al., 1996; Piccone et al., 2010b). The complete attenua-
tion of this mutant virus which contained and expressed all viral
genes provided a unique opportunity to investigate the early
events in FMDV pathogenesis as described herein.
The modulation of transcription of interferons (IFN) and IFN-
stimulated genes (ISG) in the early innate response of cattle to
FMDV infection has been recently described (Diaz-San Segundo
et al., 2011; Perez-Martin et al., 2012; Stenfeldt et al., 2012; Zhang
et al., 2006). These works have demonstrated that type I/III IFN
activity, measured using an Mx-CAT reporter system, is detectable
in serum of unvaccinated, FMDV-infected cattle with onset and
duration similar to that of viremia (Howey et al., 2012; Perez-
Martin et al., 2012; Stenfeldt et al., 2011). Additionally activation of
ISG pathways in cattle subsequent to exogenous delivery of
recombinant vectors expressing type I (e.g. IFN-α ) and type III
(IFN-λ) IFN has been characterized (Diaz-San Segundo et al., 2011;
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Perez-Martin et al., 2012). These works have demonstrated that
FMDV infection (Perez-Martin et al., 2012) and/or delivery of
recombinant vectors expressing IFN transgenes (Diaz-San Segundo
et al., 2011) result in induction of transcription of various ISGs in
peripheral blood mononuclear cells (PBMC) and tissues of cattle
that have been demonstrated to be sites of primary infection by
FMDV (Arzt et al., 2010; Pacheco et al., 2010a). ISGs that were
substantially induced included IRF-7, CCL-2, ISG-15, Mx-1, OAS1,
PKR, and RIG1 (Diaz-San Segundo et al., 2011; Perez-Martin et al.,
2012).
Recent reports from our laboratory have described a novel
method for aerosol inoculation of cattle with FMDV together with
trimodal FMDV detection systems, and the utility of using these
systems for investigation of FMD pathogenesis in vivo (Arzt et al.,
2010; Pacheco et al., 2010a). These works demonstrate that sub-
sequent to aerosolization of cattle with FMDV-O1-Manisa, the
previremic events consist of primary infection in epithelial crypts
of the nasopharynx followed by extensive ampliﬁcation in the
pneumocytes in the lungs and the establishment of viremia. In
the current study, we utilized similar experimental systems to
characterize early events in the pathogenesis of FMDV-A24-Cruzeiro
(FMDV-WT) (Rieder et al., 2005) and contrast with that of an Lpro
(inter-AUG) insertion mutant (FMDV-Mut) (Piccone et al., 2010b)
derived from the same parental virus. The data herein demonstrate
that the pathogenesis of FMDV-WT was similar to FMDV-O1-Manisa
with primary replication in nasopharynx followed by extensive
ampliﬁcation in the lungs followed by viremia and clinical disease.
By contrast, FMDV-Mut had a thoroughly attenuated phenotype
(when inoculated via aerosol) which was associated with lower
levels of replication at primary sites and lung, lack of detectable
viremia and no clinical signs. The differences between the two
viruses were associated with signiﬁcant divergence in induction of
type I/III IFN both locally and systemically. Interestingly, inoculation
of FMDV-Mut via intraepithelial lingual injection restored fully
virulent phenotype and associated IFN response. These data indi-
cate that the virulence of FMDV is dependent upon a delicate
balance of intrinsic viral qualities, host defense mechanisms, and
route of exposure.
Results
Clinical signs, systemic viral dynamics, and systemic interferon
activity (aerosol inoculated cattle)
In cattle aerosol-inoculated with FMDV-WT, the period
24–72 hpa corresponded to the transition from incubation period
to early clinical disease (Fig. 1A). At 24 hpa, animals had no clinical
signs of FMD and infectious FMDV was not detected in serum;
however, low quantity of vRNA was detected in the serum in 71%
of animals (n¼7) with mean GCN¼4.0270.36/ml and in nasal or
oral secretions of all animals (mean GCN¼4.8070.38 oral;
6.5770.38 nasal). This vRNA indicated de novo FMDV replication
rather than residual inoculum, based upon extinction of detection
of vRNA (inoculum) in samples obtained from 0 6 hpa (data not
shown). All steers inoculated with FMDV-WT had infectious virus
(determined by VI) in nasal secretions at 24 hpa (data not shown).
At 48 hpa three of four steers had one or more vesicle
(s) indicating the onset of clinical FMD. All steers were viremic
(mean serum GCN¼6.2770.20/ml; 4/4 VI positive). Oral and nasal
secretions were generally VI-positive with similar or higher
quantities of vRNA (mean GCN¼5.7771.22 oral; 7.8670.53
Fig. 1. Graphs illustrating the antemortem dynamics of FMDV infection in cattle: aerosol inoculation with FMDV-WT (A) or FMDV-Mut (B); intra-epithelial lingual
inoculation with FMDV-WT (C) or FMDV-Mut (D). Time on the X-axes is in hours post-inoculation. The left Y-axes represent log10 RNA copy numbers per ml of virus in serum
(♦), oral swabs (■) and nasal swabs (▲). The right Y-axes represent log10 IFN IU per ml in serum (X) and clinical score (shaded area).
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nasal) compared to 24 hpa. At the ﬁnal time point, 72 hpa, both
steers had increased clinical lesion scores and vRNA detection
from every clinical sample type relative to 48 hpa (mean GCN:
serum¼8.6370.26/ml, saliva¼7.7570.31/ml, nasal¼9.007
0.09/ml). All sera and secretions from FMDV-WT-aerosolized
animals were VI-positive at 72 hpa (data not shown).
In contrast to animals infected with FMDV-WT, none of the six
steers aerosol-inoculated with FMDV-Mut had clinical signs of
FMD (Fig. 1B) during the 72 hpa described herein. FMDV-Mut
infectious virus was never isolated from sera of infected animals;
however small quantities of vRNA were detected between
48–72 hpa. Mean vRNA detected in sera was signiﬁcantly less in
FMDV-Mut aerosol-inoculated steers compared to steers aeroso-
lized with FMDV-WT at all time points (24 hpa p¼0.0056; 48 hpa
po0.0001; 72 hpa p¼0.0092). vRNA and infectious FMDV-Mut
were variably detected in nasal and oral secretions with consis-
tently increasing quantities over the 24–72 hpa period, but at
uniformly lower quantities compared to animals infected with
FMDV-WT at similar time points (Fig. 1A and B). Mean vRNA
detected in saliva was signiﬁcantly less in FMDV-Mut aerosol-
inoculated steers at 48 hpa (p¼0.0496); mean vRNA detected in
nasal swabs was signiﬁcantly less in FMDV-Mut aerosol-inoculated
steers at 24 hpa (p¼0.0022) and 48 hpa (p¼0.0404).
Systemic type I/III interferon activity was investigated in time-
dependent manner in sera from aerosol and IEL-inoculated steers
(described below). Cattle that were aerosol-inoculated with
FMDV-WT had a robust and consistent type I/III IFN activity in
serum (Fig. 1A). Induction of IFN activity was regularly ﬁrst
detected in serum between 24–48 hpa and always occurred
coincident with detection of vRNA in serum. At 48 hpa all animals
had elevated activity and maximum levels were detected between
48–72 hpa. The highest single measurement of IFN activity in
serum (128.75 IU/ml) occurred at 48 hpa. Serum detection of IFN
activity was similar between 48 and 72 hpa in contrast to detec-
tion of vRNA in serum, which increased by more than 2 log10 in the
same time period. By contrast, steers aerosol-inoculated with
FMDV-Mut did not have detectable levels of type I/III IFN in serum
at any time (Fig. 1B); systemic IFN activity was statistically
signiﬁcantly higher amongst FMDV-WT-inoculated steers at 48
and 72 hpa.
Clinical signs, systemic viral dynamics, and systemic interferon
activity (intra-epithelial lingual inoculated cattle)
In order to investigate inoculation route-dependence of clinical
phenotype, viral dynamics, and systemic type I/III interferon
response of cattle inoculated with FMDV-WT and FMDV-Mut,
two steers were inoculated with each virus by conventional
intra-epithelial lingual injection and monitored similarly as
described for aerosol-inoculated cattle (Fig. 1C and D). The most
striking difference observed in these experiments was that FMDV-
Mut had a virulent phenotype when inoculated IEL (Fig. 1D). In
order to investigate if this regained virulence was due to genomic
alterations of FMDV-Mut, full length Sanger sequencing of the
entire FMDV open reading frame was performed on vesicular ﬂuid
from the earliest vesicles observed in each of the IEL-inoculated
steers. Sequencing conﬁrmed that the inter-AUG transposon was
intact and that no compensatory mutations had occurred any-
where in the open reading frame relative to the inoculated virus
(data not shown). Both steers inoculated with this virus by this
route had clinical signs of FMD including fever and vesicles at the
injection site and distant secondary sites (feet). Viremia and viral
shedding were also consistent with the dynamics of virulent
FMDV with maximum detection of vRNA in serum at 48 hpi
(7.2270.11 RNA/ml) and maximum shedding in nasal secretions
at 72 hpi (7.2270.03 RNA/ml).
Although, these data clearly indicate reconstitution of virulence in
association with IEL inoculation, FMDV-Mut was still relatively
attenuated when compared to FMDV-WT inoculated IEL at the same
dose (Fig. 1C). Within the same 72 hpi monitoring period, maximum
clinical lesion score was signiﬁcantly higher (p¼0.0337) for FMDV-
WT infected steers (16.570.88) as compared to FMDV-Mut
(8.5071.94). Similarly, IEL inoculated FMDV-WT achieved signiﬁ-
cantly higher maximum vRNA detections in serum (9.2470.05
RNA/ml; p¼0.0018) and in nasal secretion (7.8170.16 RNA/ml;
p¼0.0529) compared to FMDV-Mut (serum: 7.2270.11 RNA/ml;
nasal: 7.22þ0.12 RNA/ml). Systemic IFN activity was substantial,
but not signiﬁcantly different, in IEL-inoculated animals with either
virus (Fig. 1C and D): FMDV-WT (max 62.5574.82 U) and FMDV-
Mut (max 48.1173.01 U). Similar to animals aerosol-inoculated with
FMDV-WT, IFN activity correlated closely with detection of vRNA in
Fig. 2. Tissue-speciﬁc, timepoint-speciﬁc comparison of FMDV detection by Genome Copy Numbers and Positive Detection Prevalence (PDP) in tissues of cattle aerosol-
inoculated with either FMDV-WT or FMDV-Mut.
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serum. Thus, FMDV-Mut induced viremia, systemic FMD, and a
systemic (responsive) IFN response when delivered via the IEL route.
Tissue-speciﬁc distribution of FMDV and viral RNA in aerosol-
inoculated steers
In order to compare differences in tissue-speciﬁc viral loads
due to factors directly attributable to the inter-AUG mutation, two
parameters were deﬁned and compared across FMDV-WT and
FMDV-Mut. The ﬁrst parameter was mean genome copy number
(GCN) which was calculated from all FMDV rRT-PCR replicates
from each anatomically deﬁned tissue from all animals infected
with the same virus and euthanized at each particular time point.
The second parameter was tissue-speciﬁc FMDV positive detection
prevalence (PDP), similarly calculated for all animals infected with
the same virus and euthanized at the same time point.
At all time points and all tissues examined, both GCN and PDP
were higher for tissues of animals infected with FMDV-WT as
compared to tissues from animals infected with FMDV-Mut,
indicating a substantially higher viral load in tissues of animals
infected with FMDV-WT (Fig. 2). GCN was signiﬁcantly higher
(po0.05) for nasopharyngeal tissues at 72 hpa and for lung tissues
at 24 and 48 hpa. The greatest difference in GCN between FMDV-
WT and FMDV-Mut and lowest p-value for statistical signiﬁcance
occurred for lung tissues at 48 hpa. PDP was signiﬁcantly higher
(po0.05) for all tissue/time point combinations except for naso-
pharyngeal tissues at 72 hpa (p¼0.3192). The greatest difference
in PDP and lowest p-value for statistical signiﬁcance occurred for
lung tissues at 24 hpa (Fig. 2).
Tissue-speciﬁc type I/III IFN activity and transcription of IFN and ISG
Mean relative induction (or repression) of transcription of IFN
and ISG was characterized in various tissues of cattle aerosolized
with FMDV-WT and FMDV-Mut (Fig. 3). Multiple tissue replicates
from multiple animals were included for every time point. On the
basis of previous work delineating speciﬁc roles for distinct
anatomic regions in FMD pathogenesis (Arzt et al., 2010; Pacheco
et al., 2010a; Zhu et al., 2013), tissues were grouped into the
categories: primary infection sites (nasopharynx), intermediate
infection sites (lung) and lesion predilection sites (tongue epithe-
lium and interdigital skin). Mean fold-changes of transcription
induction were compared between tissues of animals infected
with FMDV-WT and FMDV-Mut.
At the local tissue level, the general trend was that transcrip-
tion of IFN-α, IFN-β, and IFN-λ were substantially induced (up to
2482-fold) in lung and lesion predilection site tissues of both
FMDV-WT and FMDV-Mut aerosolized animals with no signiﬁcant
difference between the effects of the two viruses (Fig. 3). Despite
similar induction of IFN transcription, ISG mRNAs had nearly
uniformly higher induction amongst FMDV-WT infected cattle
with signiﬁcant ﬁndings in every tissue class and every time
point. The overall trend of IFN/ISG transcription induction is
particularly well exempliﬁed by the lesion site tissues at 72 hpa
wherein IFN-α, IFN-β, and IFN-λ transcription were similarly
highly induced amongst both virus groups; however, ISG tran-
scription induction was signiﬁcantly higher within tissues of
FMDV-WT infected steers for all ISGs except IRF-7 (Fig. 3).
In nasopharyngeal tissues, IFN mRNAs were modestly induced
to moderately suppressed for both viruses with only a single
signiﬁcant ﬁnding of IFN-λ being suppressed more in FMDV-WT
infected animals at 72 hpa. Despite similar (i.e. not signiﬁcantly
different) changes in IFN mRNAs, there were numerous signiﬁcant
differences in relative induction of ISG mRNA between animals
infected with the two viruses. Signiﬁcantly different mean induc-
tions of ISGs were identiﬁed in all tissue categories and included
the mRNAs coding for IRF-7, CCL-2, OAS, PKR, and Mx-1 (Fig. 3); in
every case of signiﬁcant difference, the mean ISG induction was
Fig. 3. Comparison of relative induction of transcription of type I/III interferons and interferon-stimulated genes in tissues obtained from cattle aerosol-infected with FMDV-
WT or FMDV-Mutn.
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higher amongst FMDV-WT infected animals compared to FMDV-
Mut. It is also noteworthy that both viruses, most noticeably
FMDV-Mut, induced transcription of IRF-7 in all tissues between
24–48 hpa, but nearly uniformly downregulated its transcription
at 72 hpa as viral titers increased.
Both viruses effectively induced IFN transcription at lesion
predilection sites. Remarkably this was the case for FMDV-Mut-
infected animals despite lack of detection of FMD infectious virus
or RNA at such sites. However, ISG induction was only seen in
animals infected with FMDV-WT wherein virus and IFN activity
were detected at these sites.
Several tissues from FMDV-WT-infected cattle had detectable
type I/III IFN bioactivity (Fig. 3). It is noteworthy that detection of
IFN activity in tissues was generally one order of magnitude higher
than that detected in serumwhen comparison was made using units
of similar mass (i.e. IFN IU/ml for serum and IFN IU/g for tissue). At
24 hpa, one nasopharyngeal and one lung tissue had bioactivity of
932.7 IU/g and 688.7 IU/g respectively. At 48 hpa, maximum IFN
detection in nasopharyngeal tissue had decreased to 710.7 IU/g;
however, in lungs, coincident with maximum vRNA detection, IFN
bioactivity reached 4341.0 IU/g, representing the peak of pulmonary
IFN detection. At 72 hpa, the highest tissue-speciﬁc level of IFN
Fig. 4. Immunoﬂuorescent labeling of interdigital epithelium from cattle aerosol-inoculated with FMDV-WT (A–D), FMDV-Mut (E–H ), or virus-free media (Mock, I–L).
A regionally extensive vesicle cavity in FMDV-WT tissue is comprised of numerous cells containing cytokeratin, FMDV-VP1, and IFN-β. Mock and FMDV-Mut derived tissues
lack FMDV-VP1 and IFN-β staining. Simultaneous multichannel indirect immunoﬂuorescent technique, hematoxylin counterstain, 20 , bar¼50 m.
J. Arzt et al. / Virology 452-453 (2014) 12–2216
bioactivity throughout the study (6762 IU/g) was detected from the
lesion predilection tissue category (i.e. tongue epithelium), coinciding
with high levels of vRNA and vesicle formation. At this time, IFN
detection from lungs had decreased to 671 IU/g, and nasopharyngeal
tissues had no detectable IFN. The only IFN bioactivity detected in
any tissue from cattle inoculated by aerosol with FMDV-Mut
occurred in tongue epithelium at 72 hpa in the absence of any
clinical signs; this bioactivity of 414.9 IU/g was lower than any IFN
activity detected for FMDV-WT. (Fig. 3)
Microscopic characterization of animal tissues of aerosol-inoculated
cattle
With the exception of gross lesion sites, histological character-
istics and microanatomic localization of FMDV antigens were
remarkably similar regardless of the virus (FMDV-WT or FMDV-
Mut) with which cattle were aerosol-inoculated (not shown). Both
viruses were ﬁrst localized within the epithelia of MALT regions of
nasopharynx at 24 hpa. At 48–72 hpa both viruses could be
localized to lungs of infected cattle; however, cattle infected with
FMDV-WT had substantially greater quantities of lung specimens
containing virus antigen and positive tissues generally had more
antigen-positive cells compared to samples of lungs from animals
infected with the mutant virus.
The most remarkable microscopic difference between cattle
infected with the two viruses was the cavitary intraepithelial
vesiculation present at multiple pedal and oral epithelial lesion
sites, only of cattle infected with FMDV-WT (Fig. 4). Multichannel
immunoﬂuorescent microscopy indicated that the lesions were
comprised of degenerating cytokeratin-positive cells (keratino-
cytes), many of which were immunoreactive for FMDV-VP1 and/or
IFN-β. Few MHC-II containing cells were present within lesions;
however these cells uniformly lacked immunoreactivity for FMDV-
VP1 and IFN-β (Fig. 5). No vesicles were identiﬁed grossly or
microscopically in pedal or oral epithelia of FMDV-Mut infected
cattle; neither FMDV-VP1 nor IFN-β could be identiﬁed micro-
scopically in lesion predilection sites from these animals (Fig. 4).
Discussion
In order to investigate mechanisms of virulence and attenua-
tion of FMDV, experiments were conducted in which cattle were
inoculated by a simulated natural route (aerosol) or parenteral
injection (IEL) with either a mutagenized FMDV containing a
transposon insertion in the inter-AUG region of Lpro (FMDV-Mut)
or the parental infectious clone (FMDV-WT) from which the
mutant virus was derived. Previous work from our laboratory
demonstrated that FMDV-WT is virulent and FMDV-Mut is atte-
nuated in cattle by the aerosol route (Piccone et al., 2010b).
Furthermore, other than a slower replication rate for FMDV-Mut,
previous work found no major differences in basic functions or
intracellular localization of FMDV-Mut leader protease and the WT
protein (Piccone et al., 2010a). Recent work investigating various
deletion mutants of the inter-AUG (spacer) region showed differ-
ential Lpro function and cell-line speciﬁc viability dependent upon
what portion of inter-AUG sequence was retained or deleted
(Belsham, 2013). This suggests that the inter-AUG region may be
critical in determining FMDV tropism and pathogenesis in vivo.
The central hypothesis of the current work was that intensive
sampling, analysis, and comparison of animals infected with
FMDV-WT or FMDV-Mut would reveal host and viral factors that
deﬁne the nature of virulence of FMDV in cattle. Examination of
tissues and clinical samples of animals at 24–72 hpa indicated that
inoculation of FMDV-WT as opposed to FMDV-Mut determined
substantial differences in tissue-speciﬁc virus loads, variations in
transcription of several host genes, and distinct patterns of type
I/III interferon activity. Although, tissue distribution and micro-
scopic examination indicated some similarities, there were speciﬁc
differences that were linked to distinct differences in the patho-
genesis of the two viruses.
Fig. 5. Center of vesicle, interdigital epithelium, 72 hpa, FMDV-WT. (A) Most cells are keratinocytes that are labeled with anti-cytokeratin (green). (B) Many cells contain
FMDV-VP1 (red). (C) Few cells containing MHC-II (blue) are distinct from cells containing IFN-β (purple). (D) Merge indicates variable co-localization of cytokeratin, FMDV-
VP1, and IFN-β. Simultaneous multichannel indirect immunoﬂuorescent technique with differential interference contrast, 100 , bar¼10 m.
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The most readily apparent differences between the two viruses
were the complete clinical attenuation after aerosol inoculation,
failure to establish viremia (infectious virus), and relative inefﬁ-
ciency of replication of FMDV-Mut in various tissues as compared
to FMDV-WT. While it is likely that these differences in viral
dynamics reﬂect a combination of viral (intrinsic) and host
(extrinsic) factors, the association of high viral loads and virulence
is unambiguous in the current study. Both the distribution of virus
and the regional viral loads were signiﬁcantly higher for FMDV-
WT as reﬂected by the PDP and GCN parameters respectively.
Relatively low viral loads were apparent at all time points in both
antemortem samples and postmortem specimens from steers
aerosol-inoculated with FMDV-Mut. The antemortem disparity is
demonstrated by the signiﬁcant differences in maximum recovery
of vRNA from serum (5 log10 higher for FMDV-WT), nasal secre-
tions (3 log10 higher for FMDV-WT), and oral secretions (2 log10
higher for FMDV-WT). The disparity in viral loads in tissues was
most evident in lungs at 48 hpa (3 log10 higher for FMDV-WT)
however the same trend was true for every tissue and every time
point examined. Recent work from our laboratory has demon-
strated that localization of large quantities of FMDV in pulmonary
epithelial cells is a consistent ﬁnding in early stages of viremia of
FMDV aerosol-inoculated cattle (Arzt et al., 2010). The current
association of elevated pulmonary viral loads concurrently with
viremia and virulence of FMDV-WT suggests that replication of
FMDV in the lungs plays a critical role in virus generalization and
clinical disease after infection by aerosol.
The differences in host innate response to the two viruses are
complex and require consideration of compartmentalization of
effects (local and systemic) and distinct layers of regulation (e.g.
transcriptional, translational, post-translational). Since the WT
virus induced a more robust systemic and tissue-speciﬁc innate
response, it cannot be concluded that more efﬁcient induction of
IFNs and ISGs is allowed by FMDV-Mut and thus resulted in
attenuation. However, it cannot be ruled out that IFN responses
elicited prior to 24 hpa may have gone undetected yet contributed
to limiting early replication and/or dissemination of the mutant
virus. Additionally, it is plausible that the very early virus-host
interaction in vivo involves just a small number of infected cells in
which IFN responses might be differentially affected by the WT
and mutant viruses, yet these subtle differences were not detect-
able by current techniques which assay host innate responses at
the macroscopic (i.e. whole tissue) level. Furthermore, it is
possible that such IFN-susceptibility of FMDV is an important
mechanism within individual cells in vivo and that IFN limits viral
replication in such cells similarly as has been demonstrated in cell
culture (Chinsangaram et al., 2003; Diaz-San Segundo et al., 2011;
Moraes et al., 2007).
It is clear that from 0–72 hpa the virulent FMDV-WT thrived
despite substantial levels of IFN activity. Peak viremia, highest
tissue-speciﬁc viral loads and the onset of vesiculation all occur in
the context of peak type I/III interferon activity. This is consistent
with recent works that have demonstrated that the early phase of
FMD in cattle includes coincident peaks of viremia and systemic
IFN activity followed by detection of speciﬁc antibodies (Howey
et al., 2012; Perez-Martin et al., 2012; Stenfeldt et al., 2011).
However, experiments in cell culture have shown that successful
replication and spread of virulent FMDV required blocking the
expression of IFN and ISGs (Chinsangaram et al., 1999; de los
Santos et al., 2007). Similarly, in tissue culture experiments in our
laboratory, no detectable IFN activity could be detected after
infection with FMDV-WT of a primary cell culture generated from
embryonic bovine kidney cells, whilst modest activity was
detected subsequent to infection of cells with FMDV-Mut (data
not shown). These seemingly contradictory ﬁndings between cell
culture and in vivo studies suggest that complex virus-host
interactions at very early stages of infection determine the out-
come of the infection. Establishment of productive infection (in
either system) may depend upon a ﬁne balance between the rate
of replication and the timing and extent of induction of IFN and
ISG for each particular virus strain.
The current data indicates that during acute FMD peripheral tissues
contain substantially more type I IFN than is present within similar
mass or volume of blood. The greatest detection in tissues was
6762 IU/g which is more than 50-fold greater than the maximum
detection in serum of 129 IU/ml. Additionally, the microscopic co-
localization of IFN-β and FMDV antigens in vesicular tissue suggests
that infected epithelial cells are a substantial source of type I IFN.
Furthermore, co-localization of IFN- βwith cytokeratin but not MHC-II
suggests that at lesion sites, keratinocytes, but not antigen-presenting
cells, are responsible for the regionally detected IFN activity. This
ﬁnding provides the ﬁrst scientiﬁc evidence for a differential role of
infected epithelial cells versus non-infected immune cells as major
sources of type I IFN in FMDV infected tissues.
Recent work has demonstrated that ex vivo enriched plasma-
cytoid dendritic cells (pDCs) are a rich source of type I IFN in cattle
responding to FMDV, which leads the authors to suggest that these
intravascular cells are the major source of type I interferon in
response to FMDV in vivo (Reid et al., 2011). However, if intravas-
cular pDCs were the major source of IFN, then it would follow that
upon examination of individual tissues, type I/III IFN activity
would be expected to be ubiquitously present in quantities
proportional to the blood content of the tissue. Yet this was not
the case in the study described herein. Rather, detection of IFN
activity in tissues was highly restricted anatomically and tempo-
rally to sites of intense virus replication. This further supports the
premise that the tissues where virus replicates are selectively
induced to generate large quantities of IFN. The extent to which
this IFN enters the vascular space and contributes to detection of
IFN in sera remains uncertain, but it is plausible that IFN could
gain access to the systemic circulation directly through blood
capillaries or via the lymphatic system.
The induction/repression of transcription of IFN and ISG in
tissues during FMDV infection provides novel insights to the
antiviral mechanisms engaged at these sites. Previous works have
demonstrated IFN induction in PBMCs at 1dpi (Perez-Martin et al.,
2012), in NALT at 7dpi (Zhang et al., 2006), in various epithelia at
1–4dpi (Zhang et al., 2009) and repression in nasopharynx
biopsies at onset of the acute phase (Stenfeldt et al., 2012). The
general trend herein that ISG were upregulated and IFN activity
induced more in tissues from FMDV-WT infected steers further
supports the concept that a more robust antiviral response was
occurring in these animals at the time points examined herein.
Furthermore this data suggests that within infected tissues of
cattle, virulent FMDV induces interferon pathways rather than
suppresses the innate response. The inhibition of IFN response
observed in vitro in FMDV infected cells might still be occurring at
the individual cell level, but was not detectable in vivo at the
whole tissue level.
The elevated tissue-speciﬁc transcription levels of OAS, PKR, Mx-1,
IRF-7, and IP-10 (Fig. 3) provide a temporo-anatomic map of which
speciﬁc pathways may have been activated. This is consistent with
previous works that describe such ISG-expression patterns associated
with type I/III IFN activity (Sadler and Williams, 2008; Sommereyns
et al., 2008). The clearest example of antiviral activation occurred in
the lesion predilection site tissues of FMDV-WT infected steers
wherein IFN-α, β, and λ were all induced, maximum IFN bioactivity
was detected, and 6 of 7 ISGs were signiﬁcantly upregulated relative
to FMDV-Mut. An intriguing quandary is that IFN mRNAs were
similarly upregulated in various tissues (including lesion predilection
sites) of FMDV-Mut infected animals despite lack of detectable
lesions, FMDV, IFN activity, or ISG induction. The disconnect between
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induction of type I/III IFN mRNA and IFN activity or ISG induction at
lesion target sites in these animals is suggestive of activation of a
generalized (primary) IFN signal induced by the FMDV-Mut infection
of primary sites, but lack of a (secondary) IFN inducing signal such as
viral RNA at target sites (i.e. viremia). This is consistent with similar
work from our laboratory demonstrating up-regulation of ISGs after
infection with FMDV-WT prior to viremia and manifestation of
systemic disease (Diaz-San Segundo et al., 2010). The mechanism
of this activation of IFN mRNA at lesions sites remains unclear;
however, it is possible that the low levels of FMDV-Mut vRNA
detected in sera, but below the limit of local detection in tissues,
were involved in this distant transcription induction of IFN genes.
The fact that FMDV-Mut was virulent when inoculated directly
in the epithelium of the tongue is suggestive of possible mechan-
isms that mediated its attenuation under the simulated natural (i.
e. aerosol) inoculation route. A complex of inter-related mechan-
isms, likely, contributed to the reconstitution of virulence of
FMDV-Mut upon IEL-inoculation. Virus inoculated via aerosol
encounters various innate immune mechanisms in the early stages
of infection. These include the intact physical epithelial barrier, the
mucocilliary apparatus, dilution effect of secretions, and antimicro-
bial peptides such as defensins. Additionally, aerosol-inoculated
virus initially has very limited replication at minute foci within the
nasopharynx (Arzt et al., 2010). By contrast, IEL (needle) inoculation
bypasses these host barriers and defense mechanisms. Further-
more, with IEL inoculation, FMDV immediately encounters a popu-
lation of cells (keratin-rich, αV-integrin-rich epithelial cells) which
are known to be exquisitely susceptible to infection and high-titer
replication which boosts the effective inoculation dose even higher.
It is possible that virulent phenotype is a direct consequence of
the stochastic effect of a larger bolus of FMDV-Mut delivered at a
susceptible single site versus the same amount of virus spread over a
large surface of the respiratory tract. The overall effect was that the
advantages conferred by IEL inoculation (as compared to aerosol)
allowed even the intrinsically semi-competent virus to produce a
fully virulent phenotype. However, the failure of the IEL inoculated
FMDV-Mut to reach the clinical scores and viral loads of the IEL
inoculated FMDV-WT during similar time points post-infection
further demonstrates the intrinsic limitations of the mutant virus.
The current work challenges the concept that virulence or
attenuation of FMDV is determined predominantly by the virus0s
relative ability to inhibit IFN pathways. Rather, at the early stages of
infection, the intrinsic viral properties that deﬁne replicative compe-
tence may be the most important determinants of virulence.
Speciﬁcally, after simulated natural inoculation, an attenuated virus
actually induced a weaker innate response than the virulent parental
virus. At the time points examined herein, proliﬁc replication of the
virulent virus has occurred despite the robust innate immune
response. These results add complexity to our previous observations
which demonstrated that FMDV is susceptible to the antiviral effect
of type I/III IFNs and support the concept that a ﬁne balance exists
between viral proliferation and host innate immunity. Deeper under-
standing of these factors deﬁning balance between virulence and
attenuation will ultimately be useful in devising better preventive
tools such as vaccines and biotherapeutics targeting the critical early
steps in FMDV infection.
Materials and methods
Experimental animals, viruses, and inoculation systems
Twenty Holstein steers 9–12 months old, weighing 300–450 kg
were obtained from an AAALAC-accredited experimental-livestock
provider (Thomas-Morris Inc., Reisterstown, MD). All experiments
involving live animals were performed under an experimental
protocol approved by the Institutional Animal Care and Use Com-
mittee of the Plum Island Animal Disease Center. For all experiments,
animals were housed individually in a BSL-3 animal facility from
time of inoculation until time of euthanasia. Thirteen steers were
inoculated with FMDV via aerosolization (described below) of
inoculum (7 with FMDV-WT; 6 with FMDV-Mut) and subsequently
euthanized at predetermined end points at 24 h post aerosol
inoculation (hpa), 48 hpa, or 72 hpa (Table 1). Four steers were
inoculated by conventional intra-epithelial lingual (IEL) inoculation
(Henderson, 1949) with FMDV (2 with FMDV-WT; 2 with FMDV-
Mut). These IEL inoculated animals were allowed to survive through
the acute phase of FMD. Three steers were aerosol inoculated with
virus-free media and euthanized 72 hpa for the purpose of recover-
ing tissues for establishing baseline levels of cytokine mRNA.
The “wild type” FMDV utilized in experiments herein (FMDV-
WT) is an infectious clone virus of a ﬁeld isolate of FMDV-A24-
Cruzeiro (Rieder et al., 2005); the inter-AUG mutant described
herein (FMDV-Mut) was previously described and referred to as
“A24-L1123” (Piccone et al., 2010b). Brieﬂy, FMDV-Mut contains a
random, 57 nucleotide, in-frame insertion in the region located
between the two functional AUG (inter-AUG), within the leader
protease (Lpro).Virus inoculum for aerosol and IEL inoculations
consisted of 107 TCID50 FMDV in 2.0 and 0.4 ml, respectively of
Minimum Essential Media (Gibco, San Diego, CA) with 25 mM
Hepes (Gibco, San Diego, CA).
Steers were sedated with xylazine for all inoculations. Brieﬂy,
for aerosol inoculation, each steer was ﬁtted with a commercially
available aerosol delivery system (Aeromask-ES, Trudell Medical,
London, Ontario, Canada) which was placed over the muzzle
(Pacheco et al., 2010a). The mask was attached to a jet nebulizer
(Whisper Jet, Vital Signs Inc., Totowa, NJ) which was subsequently
attached to an air compressor which generated 25 psi of pressure.
Aerosolization proceeded until the complete inoculum was
expelled from the nebulizer cup (10–15 min). The same dose of
the same stock viruses was delivered by IEL inoculation to
similarly sedated steers as previously described (Pacheco et al.,
2010a). Clinical scores were based on a 20 point scale accounting
for presence of vesicles on each foot and anywhere on head (oral
cavity or nasal epithelia) as previously described (Pacheco et al.,
2010a).
Sample collection
Antemortem sampling consisted of collection of whole blood in
serum separation tubes, and undiluted oral and nasal ﬂuids with
Table 1
Assignment of steers to experimental groups.
Virus used
FMDV-WT FMDV-Mut None (mock)
Route/time
Aera/24 hpa n¼3v,t,i,h n¼2v,t,i,h N/A
Aer/48 hpa n¼2v,t,i,h n¼2v,t,i,h N/A
Aer/72 hpa n¼2v,t,i,h n¼2v,t,i,h n¼3b
IELb/10dpi n¼2v,i n¼2v,i N/A
Subscripts indicating animals0 usage.
v¼virus dynamics (antemortem)
t¼virus tissue loads (postmortem)
i¼ IFN activity (antemortem)
h¼host tissue-speciﬁc mRNA and IFN activity (postmortem)
b¼baseline host mRNA
a Aer¼aerosol inoculation.
b IEL¼ intra-epithelial lingual inoculation.
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cotton swabs. All animals were sampled prior to inoculation to
ensure FMDV – free status and lack of elevated IFN levels that
might interfere with initial FMDV replication. Animals were
additionally sampled at several time points throughout the dura-
tion of the experiment which varied according to goals of the
individual experiments. Swabs and serum tubes were transported
from the animal room to the laboratory on ice and were imme-
diately centrifuged for harvesting of serum, saliva, and nasal
secretion. Samples were then stored at 70 1C until time of
processing.
Steers were euthanized at predetermined time points regard-
less of clinical progression of disease in individual animals.
Postmortem sample collection schemes were predetermined and
standardized with minor variation among individual animals
based upon the expected stage of disease at the time of euthana-
sia. Necropsies were performed immediately subsequent to eutha-
nasia. Detailed descriptions of tissue designations and collection
strategies has been published previously (Pacheco et al., 2010a).
For the current study, tissues analyzed were nasopharynx
(8 distinct specimens per animal from dorsal soft palate and roof
of nasopharynx), lung (18 distinct specimens per animal from
different levels of lung), and lesion predilection sites (up to 12
distinct specimens from dental pad, tongue and foot epithelium).
For each anatomically deﬁned specimen, three 30–50 mg tissue
samples were aliquoted into separate screw-cap 1.5 ml tubes and
frozen immediately in liquid nitrogen for transfer within 2 h to a
70 1C freezer in which they were stored until the time of
processing. An adjacent specimen from each tissue was placed in
a cryomold, embedded in Optimal Cutting Temperature Com-
pound (OCT) (Sakura Finetek, Torrance, CA), frozen on a bath of
liquid nitrogen, and stored at –70 1C for immunomicroscopy.
Foot-and-mouth disease vRNA detection
For tissues, two samples of each specimen were thawed and
immediately macerated in a TissueLyser bead beater (Qiagen,
Valencia, CA) as previously described (Pacheco et al., 2010a).
RNAwas extracted using Ambion0s MagMax-96 Viral RNA Isolation
Kit (Ambion, Austin, TX) on a King Fisher-96 Magnetic Particle
Processor (Thermo Scientiﬁc, Waltham, MA). Once extracted, vRNA
was detected by real-time reverse transcription polymerase chain
reaction (rRT-PCR) on the ABI 7000 system (Applied Biosystems,
Austin, TX) as previously described (Callahan et al., 2002). Samples
with cycle threshold (Ct) values o40 were considered positive.
Antemortem samples (serum and swabs) were processed similarly
with the exception that a single extraction was performed on each
sample and subsequently used for 2 replicate rRT-PCR reactions.
Foot-and-mouth disease virus isolation
Virus isolation (VI) was performed separately on the duplicate
samples of each tissue on BHK-21 cells as previously described
(Pacheco et al., 2010b). Subsequent to evaluation of cytopathic
effect (CPE), FMDV-positivity/negativity was conﬁrmed by rRT-PCR
on cell culture supernatants. Samples which had no CPE, but from
which vRNA was detected by rRT-PCR were passed a second time
in BHK-21 cells.
Host IFN and ISG mRNA detection and analyses
In order to establish baseline expression of host genes,
30–50 mg of tissue specimens were individually lysed by adding
600 ml of RLT lysis buffer (Qiagen, Valencia, CA) and macerating
using the rotor-stator method. Approximately 600 ml of homoge-
nate was transferred to a Qiagen Qiashredder (Qiagen), and total
RNA was subsequently isolated using an RNeasy kit (Qiagen) as
recommended by the manufacturer. RNA concentrations were
determined using a NanoDrop ND-1000 spectrophotometer.
1.0 mg of RNA was treated with DNase I per manufacturer0s
instructions (Sigma, St. Louis, MO.) and total RNA was reverse
transcribed into cDNA using random hexamers (Thermo Scientiﬁc
Hanover Park, IL.) per manufacturer0s instructions. Samples were
thermocycled at 25 1C, for 10 min, 37 1C for 60 min, and 95 1C for
5 min. The cDNA was then diluted with distilled water 1:8 in a
ﬁnal volume of 200 ml.
Baseline levels of expression of 10 host genes of interest were
established from individual tissues of mock-inoculated steers
(n¼3) by rPCR systems as previously described (Diaz-San Segundo
et al., 2011; Muller-Doblies et al., 2002; Taubert et al., 2006). cDNA
was run in triplicate and averaged for each individual specimen.
The triplicate averages of the 3 steers were then averaged to
generate the negative control baseline Ct for each tissue for all
11 genes of interest. cDNA rPCR was carried out in 25 mL reactions
on the ABI 7000 Sequence Detection System using Taqman
Universal PCR Master Mix (Applied Biosystems, Foster City, CA.).
Samples were thermocycled at 50 1C for 2 min, 95 1C for 10 min,
and 40 cycles of 95 1C for 15 s and 60 1C for 60 s.
Experimental tissues (i.e. from FMDV-infected steers) were
collected, processed, and analyzed for expression of the 11 genes
of interest as described above with the exception that tissues were
homogenized in 600 mL of Minimum Essential Media (Gibco,
San Diego, CA) to allow for further down-stream processing for
interferon type I/III activity detection (described below). The
relative mRNA gene expression for tissues of FMDV-inoculated
animals was calculated by comparison to the tissue-speciﬁc,
3-steer negative control baseline data (generated above) using
the previously described ΔΔCt method (Pfafﬂ, 2001). The Pfafﬂ
method determines the relative expression of the target gene in
comparison to a reference gene for which glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used. This relative quan-
tiﬁcation was then compared to the baseline levels of expression
(ΔCt relative to GAPDH) to generate the fold-change of expression
amongst infected animals as compared to uninfected (i.e. base-
line). The individual tissue fold-changes were averaged across
virus-speciﬁc, anatomic-speciﬁc, and timepoint-speciﬁc categories
to generate the tissue speciﬁc means presented herein. “Nasophar-
ynx” fold-changes represent the mean of the individual fold-changes
determined for all dorsal soft palate and dorsal nasopharynx tissues
at each time-point (6 distinct tissues per time point). Similarly,
“Lung” is the mean of all fold changes for individual tissues from
various level of lung (2 distinct tissues per time point) whilst “Lesion
Sites” represents the mean of all values from tongue and interdigital
cleft epithelium (4 distinct tissues per time point). For the ﬁnal
output, the mean fold changes were compared by student0s t-test
across the variable “inoculation virus used” to determine if there was
signiﬁcant difference in expression of a given cytokine, anatomic site,
timepoint combination based solely upon infection with FMDV-WT
vs. FMDV-Mut.
Quantiﬁcation of type I/III interferon in sera and tissues
An MxA protein chloramphenicol Acetyltransferase (Mx-CAT)
reporter gene assay was used to quantitate interferon activity in
serum and tissue macerate samples as previously described (Fray
et al., 2001). For each assay Madin-Darby bovine kidney-t2
(MDBK-t2) cells, stably transfected with a plasmid containing a
human MxA promoter driving a chloramphenicol acetyltransferase
cDNA, were plated at a density of 2104 per well in 24 well plates.
After 18–20 h of incubation at 37 1C, 5% CO2, the monolayer was
rinsed with serum-free media and replaced with 150 ml/well of
Dulbecco0s Modiﬁed Eagle Medium with 1% FBS, 10 μg of blastici-
din/ml culture medium and 100 ml of sample or recombinant
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human IFN-α 2a protein standard (PBL Biomedical labs). Plates
were incubated for 22–24 h at 37 1C in 5.0% CO2.
The following day CAT expression was determined using a
commercial ELISA kit (Roche Diagnostics) following the man-
ufacturer0s instructions. In brief, cells were lysed for 30 min with
Triton X-100 lysis buffer and 200-μL aliquots were added in
duplicate to wells of the CAT-ELISA 96-well plate. A standard
curve was generated in units of international units per ml (IU/ml)
from twofold serial dilutions of recombinant human IFN-α 2a (PBL
Biomedical labs). The interferon levels of the unknown samples
were calculated by extrapolation from the standard curve run on
the same day using the same MDBK-t2 cells. For tissue samples,
IU/g was calculated based upon the dilution of original tissue
in media.
Quantitative analyses of FMDV in bovine tissues and ﬂuids
Ct values generated by FMDV rRT-PCR from experimental
specimens were converted to FMDV RNA genome copies per mg
as previously described (Arzt et al., 2010). The Ct positivity cutoff
for tissues of 40 corresponded to a detection threshold value of
2.52 log10 FMDV RNA copies/mg (RNA/mg) of tissue. FMDV rRT-
PCR results were expressed as the mean log10 FMDV RNA copies/
mg (RNA/mg) for all anatomically similar tissues from animals
infected with the same virus and sampled at each time point.
Similarly, for antemortem samples (sera/swabs), data herein
represents the mean log10 FMDV RNA copies/ml (RNA/ml) from
all animals infected with the same virus and sampled at each time
point. The Ct positivity cutoff of 45 corresponded to a detection
threshold value of 2.69 log10 FMDV RNA copies per ml of serum or
swab sample.
Tissue speciﬁc viral loads were further analyzed by deﬁning
two parameters as follows. For each anatomically deﬁned tissue,
the mean genome copy number (GCN) was calculated from all rRT-
PCR replicates of the tissue obtained from all animals infected with
the same virus and euthanized at that timepoint. Additionally, a
tissue-speciﬁc, timepoint-speciﬁc FMDV positive detection per-
centage (PDP) was deﬁned and calculated from all animals
infected with the same virus and euthanized at the same time-
point as: Number of Positive Test Results (VI or rRT-PCR)CNumber
of Test Events (VI and rRT-PCR). Mean GCNs were statistically
compared across experimental groups with student0s t-test for
means in GraphPad QuickCalcs software; PDPs were statistically
compared across experimental groups using students t-test for
proportions in Statistics Calculator 4.0 from StatPac. For both tests,
the critical level for signiﬁcance was deﬁned as p¼0.05. All
comparisons not speciﬁcally indicated as “signiﬁcant” in the text
or ﬁgures, are purely descriptive (i.e. non-signiﬁcant or statistical
signiﬁcance was not established).
Immunomicroscopy
Microscopic localization of FMDV antigens and host proteins
was performed in cryosections as previously described (Arzt et al.,
2009). Brieﬂy, tissue sections were blocked for 2 h at 20 1C;
primary antibodies were diluted in blocking buffer and applied
to tissue sections for 18 h at 4 1C. For multichannel immunoﬂuor-
escence (MIF), detection was performed with goat anti-rabbit and
goat anti-mouse isotype-speciﬁc secondary antibodies labeled
with AlexaFluor dyes (AF – 350, 488, 594, 647). Slides were
examined with a wide-ﬁeld, epiﬂuorescence microscope, and
images were captured with a cooled, monochromatic digital
camera. Images of individual detection channels were adjusted
for contrast and brightness and merged in commercially available
software (Adobe Photoshop, CS2). Mouse monoclonal anti-FMDV-
VP1 has been described previously (Baxt et al., 1989). Antibodies
used to label cell markers in MIF experiments were mouse
monoclonal anti-pancytokeratin plus (Biocare #CM162), anti-
MHCII (AbD Serotec, MCA2225PE) and rabbit polyclonal anti-IFN-
β (kindly provided by Dr. James Zhu).
For each MIF experiment, a duplicate, negative-control serial
section treated with an isotype-matched irrelevant antibody or
isotype control reagent of similar concentration was included.
Additional negative control tissue sections were prepared from a
steer that received a virus-free aerosol inoculum and was eutha-
nized 72 hpa. MIF labeling was considered positive when there
was an intense cell-associated signal within the experimental
tissue with the absence of such staining in the negative controls.
Acknowledgments
This research was funded primarily by ARS-CRIS Project 1940-
32000-057-00D. Additional funding came from an interagency
agreement with the Science and Technology Directorate of the U.S.
Department of Homeland Security under Award number HSHQDC-
11-X-00189.
The authors wish to acknowledge Dr. James Zhu for providing
anti-Bovine IFN-β. Madin-Darby bovine kidney-t2 (MDBK-t2) and
Mx CAT ELISA technology were kindly provided by Dr. Bryan
Charleston, Pirbright Institute. We thank Dr. Manuel Borca and
Dr. Carolina Stenfeldt for critical review of the manuscript.
References
Alexandersen, S., Quan, M., Murphy, C., Knight, J., Zhang, Z., 2003. Studies of
quantitative parameters of virus excretion and transmission in pigs and cattle
experimentally infected with foot-and-mouth disease virus. J. Comp. Pathol.
129, 268–282.
Arzt, J., Baxt, B., Grubman, M.J., Jackson, T., Juleff, N., Rhyan, J., Rieder, E., Waters, R.,
Rodriguez, L.L., 2011a. The pathogenesis of foot-and-mouth disease II: viral
pathways in swine, small ruminants, and wildlife; myotropism, chronic
syndromes, and molecular virus-host interactions. Transbound Emerg. Dis.
58, 305–326.
Arzt, J., Gregg, D.A., Clavijo, A., Rodriguez, L.L., 2009. Optimization of immunohis-
tochemical and ﬂuorescent antibody techniques for localization of foot-and-
mouth disease virus in animal tissues. J. Vet. Diagn. Invest. 21, 779–792.
Arzt, J., Juleff, N., Zhang, Z., Rodriguez, L.L., 2011b. The pathogenesis of foot-and-
mouth disease I: viral pathways in cattle. Transbound Emerg. Dis. 58, 291–304.
Arzt, J., Pacheco, J.M., Rodriguez, L.L., 2010. The early pathogenesis of foot-and-
mouth disease in cattle after aerosol inoculation: identiﬁcation of the naso-
pharynx as the primary site of infection. Vet. Pathol. 47, 1048–1063.
Baxt, B., Vakharia, V., Moore, D.M., Franke, A.J., Morgan, D.O., 1989. Analysis of
neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease
virus. J. Virol. 63, 2143–2151.
Belsham, G.J., 2013. Inﬂuence of the Leader protein coding region of foot-and-
mouth disease virus on virus replication. J. Gen. Virol. 94, 1486–1495.
Borca, M.V., Pacheco, J.M., Holinka, L.G., Carrillo, C., Hartwig, E., Garriga, D., Kramer,
E., Rodriguez, L., Piccone, M.E., 2012. Role of arginine-56 within the structural
protein VP3 of foot-and-mouth disease virus (FMDV) O1 Campos in virus
virulence. Virology 422, 37–45.
Brown, C.C., Piccone, M.E., Mason, P.W., McKenna, T.S., Grubman, M.J., 1996.
Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in
cattle. J. Virol. 70, 5638–5641.
Callahan, J.D., Brown, F., Osorio, F.A., Sur, J.H., Kramer, E., Long, G.W., Lubroth, J.,
Ellis, S.J., Shoulars, K.S., Gaffney, K.L., Rock, D.L., Nelson, W.M., 2002. Use of a
portable real-time reverse transcriptase-polymerase chain reaction assay for
rapid detection of foot-and-mouth disease virus. J. Am. Vet. Med. Assoc. 220,
1636–1642.
Chinsangaram, J., Mason, P.W., Grubman, M.J., 1998. Protection of swine by live and
inactivated vaccines prepared from a leader proteinase-deﬁcient serotype A12
foot-and-mouth disease virus. Vaccine 16, 1516–1522.
Chinsangaram, J., Moraes, M.P., Koster, M., Grubman, M.J., 2003. Novel viral disease
control strategy: adenovirus expressing alpha interferon rapidly protects swine
from foot-and-mouth disease. J. Virol. 77, 1621–1625.
Chinsangaram, J., Piccone, M.E., Grubman, M.J., 1999. Ability of foot-and-mouth
disease virus to form plaques in cell culture is associated with suppression of
alpha/beta interferon. J. Virol. 73, 9891–9898.
de los Santos, T., Diaz-San Segundo, F., Grubman, M.J., 2007. Degradation of nuclear
factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81,
12803–12815.
Diaz-San Segundo, F., Moraes, M.P., de Los Santos, T., Dias, C.C., Grubman, M.J., 2010.
Interferon-induced protection against foot-and-mouth disease virus infection
J. Arzt et al. / Virology 452-453 (2014) 12–22 21
correlates with enhanced tissue-speciﬁc innate immune cell inﬁltration and
interferon-stimulated gene expression. J. Virol. 84, 2063–2077.
Diaz-San Segundo, F., Weiss, M., Perez-Martin, E., Koster, M.J., Zhu, J., Grubman, M.J.,
de los Santos, T., 2011. Antiviral activity of bovine type III interferon against
foot-and-mouth disease virus. Virology 413, 283–292.
Fray, M.D., Mann, G.E., Charleston, B., 2001. Validation of an Mx/CAT reporter gene
assay for the quantiﬁcation of bovine type-I interferon. J. Immunol. Methods
249, 235–244.
Gladue, D.P., O’Donnell, V., Baker-Branstetter, R., Holinka, L.G., Pacheco, J.M.,
Fernandez-Sainz, I., Lu, Z., Brocchi, E., Baxt, B., Piccone, M.E., Rodriguez, L.,
Borca, M.V., 2012. Foot-and-mouth disease virus nonstructural protein 2C
interacts with Beclin1, modulating virus replication. J. Virol. 86, 12080–12090.
Grubman, M.J., Baxt, B., 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17,
465–493.
Henderson, W., 1949. The Quantitative Study of Foot-and-Mouth Disease Virus.
Agricultural Research Council, Report Series 8.
Howey, R., Bankowski, B., Juleff, N., Savill, N.J., Gibson, D., Fazakerley, J., Charleston,
B., Woolhouse, M.E., 2012. Modelling the within-host dynamics of the foot-and-
mouth disease virus in cattle. Epidemics 4, 93–103.
Lawrence, P., Schafer, E.A., Rieder, E., 2012. The nuclear protein Sam68 is cleaved by
the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV
infection of host cells. Virology 425, 40–52.
Moraes, M.P., de Los Santos, T., Koster, M., Turecek, T., Wang, H., Andreyev, V.G.,
Grubman, M.J., 2007. Enhanced antiviral activity against foot-and-mouth
disease virus by a combination of type I and II porcine interferons. J. Virol.
81, 7124–7135.
Muller-Doblies, D., Ackermann, M., Metzler, A., 2002. In vitro and in vivo detection
of Mx gene products in bovine cells following stimulation with alpha/beta
interferon and viruses. Clin. Diagn. Lab. Immunol. 9, 1192–1199.
Pacheco, J.M., Arzt, J., Rodriguez, L.L., 2010a. Early events in the pathogenesis of
foot-and-mouth disease in cattle after controlled aerosol exposure. Vet. J. 183,
46–53.
Pacheco, J.M., Gladue, D.P., Holinka, L.G., Arzt, J., Bishop, E., Smoliga, G., Pauszek, S.J.,
Bracht, A.J., O’Donnell, V., Fernandez-Sainz, I., Fletcher, P., Piccone, M.E.,
Rodriguez, L.L., Borca, M.V., 2013. A partial deletion in non-structural protein
3A can attenuate foot-and-mouth disease virus in cattle. Virology 446,
260–267.
Pacheco, J.M., Piccone, M.E., Rieder, E., Pauszek, S.J., Borca, M.V., Rodriguez, L.L.,
2010b. Domain disruptions of individual 3B proteins of foot-and-mouth disease
virus do not alter growth in cell culture or virulence in cattle. Virology 405,
149–156.
Perez-Martin, E., Weiss, M., Diaz-San Segundo, F., Pacheco, J.M., Arzt, J., Grubman,
M.J., de los Santos, T., 2012. Bovine type III interferon signiﬁcantly delays and
reduces the severity of foot-and-mouth disease in cattle. J. Virol. 86,
4477–4487.
Pfafﬂ, M.W., 2001. A new mathematical model for relative quantiﬁcation in real-
time RT-PCR. Nucleic Acids Res. 29, e45.
Piccone, M.E., Diaz-San Segundo, F., Kramer, E., Rodriguez, L.L., de los Santos, T.,
2010a. Introduction of tag epitopes in the inter-AUG region of foot and mouth
disease virus: effect on the L protein. Virus Res. 155, 91–97.
Piccone, M.E., Pacheco, J.M., Pauszek, S.J., Kramer, E., Rieder, E., Borca, M.V.,
Rodriguez, L.L., 2010b. The region between the two polyprotein initiation
codons of foot-and-mouth disease virus is critical for virulence in cattle.
Virology 396, 152–159.
Reid, E., Juleff, N., Gubbins, S., Prentice, H., Seago, J., Charleston, B., 2011. Bovine
plasmacytoid dendritic cells are the major source of type I interferon in
response to foot-and-mouth disease virus in vitro and in vivo. J. Virol. 85,
4297–4308.
Rieder, E., Henry, T., Duque, H., Baxt, B., 2005. Analysis of a foot-and-mouth disease
virus type A24 isolate containing an SGD receptor recognition site in vitro and
its pathogenesis in cattle. J. Virol. 79, 12989–12998.
Sadler, A.J., Williams, B.R., 2008. Interferon-inducible antiviral effectors. Nat. Rev. 8,
559–568.
Sommereyns, C., Paul, S., Staeheli, P., Michiels, T., 2008. IFN-lambda (IFN-lambda) is
expressed in a tissue-dependent fashion and primarily acts on epithelial cells
in vivo. PLoS Pathog. 4, e1000017.
Stenfeldt, C., Heegaard, P.M., Stockmarr, A., Belsham, G.J., 2012. Modulation of
cytokine mRNA expression in pharyngeal epithelial samples obtained from
cattle infected with foot-and-mouth disease virus. J. Comp. Pathol. 146,
243–252.
Stenfeldt, C., Heegaard, P.M., Stockmarr, A., Tjornehoj, K., Belsham, G.J., 2011.
Analysis of the acute phase responses of Serum Amyloid A, Haptoglobin and
Type 1 Interferon in cattle experimentally infected with foot-and-mouth
disease virus serotype O. Vet. Res. 42, 66.
Taubert, A., Zahner, H., Hermosilla, C., 2006. Dynamics of transcription of immu-
nomodulatory genes in endothelial cells infected with different coccidian
parasites. Vet. Parasitol. 142, 214–222.
Uddowla, S., Hollister, J., Pacheco, J.M., Rodriguez, L.L., Rieder, E., 2012. A safe foot-
and-mouth disease vaccine platform with two negative markers for differen-
tiating infected from vaccinated animals. J. Virol. 86, 11675–11685.
Zhang, Z., Ahmed, R., Paton, D., Bashiruddin, J.B., 2009. Cytokine mRNA responses in
bovine epithelia during foot-and-mouth disease virus infection. Vet. J. 179,
85–91.
Zhang, Z., Bashiruddin, J.B., Doel, C., Horsington, J., Durand, S., Alexandersen, S.,
2006. Cytokine and toll-like receptor mRNAs in the nasal-associated lymphoid
tissues of cattle during foot-and-mouth disease virus infection. J. Comp. Pathol.
134, 56–62.
Zhu, J.J., Arzt, J., Puckette, M.C., Smoliga, G.R., Pacheco, J.M., Rodriguez, L.L., 2013.
Mechanisms of foot-and-mouth disease virus tropism inferred from differential
tissue gene expression. PLoS One 8, e64119.
J. Arzt et al. / Virology 452-453 (2014) 12–2222
